Cargando…
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts
Even though pancreatic ductal adenocarcinoma (PDAC) is associated with fibrotic stroma, the molecular pathways regulating the formation of cancer associated fibroblasts (CAFs) are not well elucidated. An epigenomic analysis of patient-derived and de-novo generated CAFs demonstrated widespread loss o...
Autores principales: | Bhagat, Tushar D, Von Ahrens, Dagny, Dawlaty, Meelad, Zou, Yiyu, Baddour, Joelle, Achreja, Abhinav, Zhao, Hongyun, Yang, Lifeng, Patel, Brijesh, Kwak, Changsoo, Choudhary, Gaurav S, Gordon-Mitchell, Shanisha, Aluri, Srinivas, Bhattacharyya, Sanchari, Sahu, Srabani, Bhagat, Prafulla, Yu, Yiting, Bartenstein, Matthias, Giricz, Orsi, Suzuki, Masako, Sohal, Davendra, Gupta, Sonal, Guerrero, Paola A, Batra, Surinder, Goggins, Michael, Steidl, Ulrich, Greally, John, Agarwal, Beamon, Pradhan, Kith, Banerjee, Debabrata, Nagrath, Deepak, Maitra, Anirban, Verma, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874475/ https://www.ncbi.nlm.nih.gov/pubmed/31663852 http://dx.doi.org/10.7554/eLife.50663 |
Ejemplares similares
-
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer
por: Zhang, Yang, et al.
Publicado: (2022) -
Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer
por: Zhang, Yang, et al.
Publicado: (2022) -
Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways
por: Bhattacharyya, Sanchari, et al.
Publicado: (2017) -
The role of stromal cancer-associated fibroblasts in pancreatic cancer
por: von Ahrens, Dagny, et al.
Publicado: (2017) -
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
por: Rahmani, Nora E., et al.
Publicado: (2021)